MedPath

Towards the development of a personalised E-Health intervention for use in community pharmacies to analyse and improve medication non-adherence in people with type 2 diabetes mellitus, who are non-adherent to oral blood glucose and/or blood pressure lowering drugs.

Completed
Conditions
10018424
diabetes
Type 2 diabetes mellitus
Registration Number
NL-OMON55758
Lead Sponsor
Vrije Universiteit Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

- People with type 2 diabetes mellitus that are non-adherent to oral blood
glucose and/or bloodpressure lowering drugs.
- Participants aged 35-75 years.
- Mobile phone user.

Exclusion Criteria

- People in which adherence data is invalid for instance due to hospital
admission.
- People that use medication-intake supporting pill packaging services provided
by the pharmacy.
- People that suffer from major psychiatric disorders.
- People that are *starters*, meaning that they started using the medicine
somewhere in the period in which the dispensing score was calculated.
- People that are *stoppers*, meaning that they did not have a medicine
dispatch in the last four months of the period in which the dispensing score
was calculated.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary study outcome is medication adherence (measured with change in a<br /><br>telephone pill count). </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The secondary study parameters are:<br /><br>- Systolic blood pressure (registry data)<br /><br>- HbA1c (registry data)<br /><br>- Medication adherence (MARS-5 questionnaire)<br /><br>- Attitude and beliefs toward medication (BMQ specific questionnaire)<br /><br>- Satisfaction with diabetes treatment (DTSQs+c questionnaire)<br /><br>- Quality of life (EQ-5D-5L questionnaire)<br /><br>- Medical and productivity costs (iMTA costs questionnaire)<br /><br><br /><br>The other study parameters are:<br /><br>- Barriers and facilitators that people with type 2 diabetes and pharmacists<br /><br>experience in the use of the intervention.<br /><br>- Refinement of the non-adherence profiling algorithm after evaluation of the<br /><br>intervention. </p><br>
© Copyright 2025. All Rights Reserved by MedPath